Dr. Hajjar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5303 Harry Hines Blvd
Dallas, TX 75390Phone+1 323-442-5100Fax+1 214-645-8801
Summary
- Dr. Ihab Hajjar is an Internist, Geriatrician, and a Dementia specialist in Atlanta, GA. He is an Associate Professor of Medicine and Neurology at Emory University . He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice for more than 20 years. He is experienced in Cognitive disorders, behavioral neurology / neuropsychiatry, hypertension, cerebrovascular disease, advanced neuroimaging, and ageing.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Geriatric Medicine (Internal Medicine), 1998 - 2000
Cleveland Clinic FoundationResidency, Internal Medicine, 1995 - 1998
American University of Beirut Faculty of MedicineClass of 1994
Certifications & Licensure
CA State Medical License 2010 - Present
TX State Medical License 2022 - 2025
GA State Medical License 2013 - 2022
NC State Medical License 2020 - 2022
AL State Medical License 2020 - 2020
MA State Medical License 2006 - 2012
SC State Medical License 2000 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Geriatric Medicine
- Join now to see all
Clinical Trials
- The Antihypertensives and Vascular, Endothelial and Cognitive Function Trial Start of enrollment: 2008 Jan 01
- CAndesartan vs LIsinopril Effects on the BRain Start of enrollment: 2014 Aug 20
- Candesartan's Effects on Alzheimer's Disease And Related Biomarkers Start of enrollment: 2016 Jun 30
- Join now to see all
Publications & Presentations
PubMed
- Technology literacy and access to digital resources for remote assessment among adults enrolled in Alzheimer's disease research.Maureen Okafor, Zhiyi Yang, Kayci L Vickers, Katherine Sanders, Najé Simama
Journal of Alzheimer's Disease. 2024-12-11 - Author Correction: APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes.Joel W Blanchard, Leyla Anne Akay, Jose Davila-Velderrain, Djuna von Maydell, Hansruedi Mathys
Nature. 2024-12-01 - Associations Between High-Density Lipoprotein Cholesterol Efflux and Brain Grey Matter Volume.John M Giacona, Jijia Wang, Rong Zhang, Brendan J Kelley, Ihab Hajjar
Journal of Clinical Medicine. 2024-10-18
Journal Articles
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentIhab Hajjar, Allan Levey, JAMA Network Open
Authored Content
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 2020
Press Mentions
Arterial Stiffening Influences Neurodegeneration, Other 'Adverse Brain Outcomes in Aging'June 1st, 2021- Aortic Stiffening Linked to Alzheimer’s BiomarkersJune 1st, 2021
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults with Executive Mild Cognitive ImpairmentAugust 3rd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
